Australian Clinical Labs (ACL) Stock Overview

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.

ACL Stock Information

Symbol

ACL

Address

1868-1892 Dandenong RoadClayton, VIC 3168Australia

Founded

Trading hours

10:00 AM - 4:00 PM AEST

Website

https://www.clinicallabs.com.au

Country

🇦🇺 Australia

Phone Number

61 1 3004 53688

Australian Clinical Labs (ACL) Price Chart

Australian Clinical Labs Overview: Key Details and Summary

Stock data	2023	Change
Price	$2.39	N/A
Market Cap	$483.38M	N/A
Shares Outstanding	201.83M	0.27%
Employees	5.12K	N/A
Shareholder Equity	172.67M	-25.75%

Valuation	2023	Change
P/S Ratio	1.03	N/A
P/B Ratio	2.80	N/A

Growth	2023	Change
Return on Equity	0.1412	N/A

Earnings	2023	Change
Revenue	$468.23M	N/A
Earnings	$24.38M	N/A
Gross Margin	0.8178	N/A
Operating Margin	0.0751	N/A
Net income margin	0.0521	N/A

Financial Strength	2023	Change
Total Assets	$391.65M	N/A
Total Debt	$214.00M	N/A
Cash on Hand	$13.50M	N/A
Debt to Equity	$1.59	38.35%
Cash to Debt	0.0631	-37.24%
Current Ratio	0.6170	-2.75%